title: Indian health groups welcome country's first compulsory licence.
authors.forename: Ganapati
authors.initials: G
authors.lastname: Mudur
mesh_terms: D000970:Antineoplastic Agents / Q000191:economics; D001557:Benzenesulfonates / Q000191:economics; D016527:Drug Costs; D004345:Drug Industry; D016568:Drugs, Generic; D006801:Humans; D007194:India; D008004:Licensure; D009536:Niacinamide / Q000031:analogs & derivatives; D010330:Patents as Topic; D010671:Phenylurea Compounds; D011725:Pyridines / Q000191:economics; D000077157:Sorafenib
chemical_list: D000970:Antineoplastic Agents; D001557:Benzenesulfonates; D016568:Drugs, Generic; D010671:Phenylurea Compounds; D011725:Pyridines; D009536:Niacinamide; D000077157:Sorafenib